Structural basis for FGF receptor dimerization and activation

Cell

Volumn 98, Issue 5, 1999, Pages 641-650

  Plotnikov, Alexander N ^a   Schlessinger, Joseph ^a   Hubbard, Stevan R ^a   Mohammadi, Moosa ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; HEPARIN;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DIMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0033520472     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80051-3     Document Type: Article

References (57)

1. Avivi, A., Yayon, A., and Givol, D. (1993). A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEES Lett. 330, 249-252.
2. Bateman, A., and Chothia, C. (1995). Outline structures for the extracellular domains of the fibroblast growth factor receptors. Nat. Struct. Biol. 2, 1068-1074.
3. Bellot, F., Crumley, G., Kaplow, J.M., Schlessinger, J., Jaye, M., and Dionne, C.A. (1991). Ligand-induced transphosphorylation between different FGF receptors. EM BO J. 10, 2849-2854.
4. Blaschuk, O.W., Sullivan, Ft., David, S., and Pouliot, Y. (1990). Identification of a cadherin cell adhesion recognition sequence. Dev. Biol. 739, 227-229.
5. Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, U.S., Kuszewski, J., Nigles, M., Pannu, N.S., et al. (1998). Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta. Crystallogr. D 54, 905-921.
6. Burgess, W.H., and Maciag, T. (1989). The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606.
7. Cheon, H.G., LaRochelle, W.J., Bottaro, D.P., Burgess, W.H., and Aaronson, S.A. (1994). High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc. Natl. Acad. Sei. USA 91, 989-993.
8. Dell, K.R., and Williams, L.T. (1992). A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulinlike domain confers ligand binding specificity. J. Biol. Chem. 267, 21225-21229.
9. Doherty, P., and Walsh, F.S. (1996). CAM-FGF receptor interactions: a model for axonal growth. Mol. Cell. Neurosci. 8, 99-111.
10. Doherty, P., Williams, E., and Walsh, F.S. (1995). A soluble chimeric form of the L1 glycoprotein stimulates neurite outgrowth. Neuron 14, 57-66.
11. Eriksson, A.E., Cousens, L.S., Weaver, L.H., and Matthews, B.W. (1991). Three-dimensional structure of human basic fibroblast growth factor. Proc. Natl. Acad. Sei. USA 88, 3441-3445.
12. Faham, S., Hileman, R.E., Fromm, U.R., Linhardt, R.J., and Rees, D.C. (1996). Heparin structure and interactions with basic fibroblast growth factor. Science 277, 1116-1120.
13. Galzie, Z., Kinsella, A.R., and Smith, U.A. (1997). Fibroblast growth factors and their receptors. Biochem. Cell. Biol. 75, 669-685.
14. Gao, G., and Goldfarb, M. (1995). Heparin can activate a receptor tyrosine kinase. EM BO J. 14, 2183-2190.
15. Holden, H.M., Ito, M., Hartshorne, D.U., and Rayment, I. (1992). X-ray structure determination of telokin, the C-terminal domain of myosin light chain kinase, at 2.8 Å resolution. J. Mol. Biol. 227, 840-851.
16. Jaye, M., Schlessinger, J., and Dionne, C.A. (1992). Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta 7735, 185-199.
17. Johnson, D.E., and Williams, L.T. (1993). Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41.
18. Johnson, D.E., Lee, P.L., Lu, J., and Williams, L.T. (1990). Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10, 4728-4736.
19. Johnson, D.E., Lu, J., Chen, H., Werner, S., and Williams, L.T. (1991). The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptorforms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 77, 4627-4634.
20. Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. (1991). Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119.
21. Kan, M., Wang, F., Xu, J., Crabb, J.W., Hou, J., and McKeehan, W.L. (1993). An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259, 1918-1921.
22. Kobrin, M.S., Yamanaka, Y., Friess, H., Lopez, M.E., and Korc, M. (1993). Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res. 53, 4741-4744.
23. Kouhara, H., Hadari, Y.R., Spivak-Kroizman, T., Schilling, J., BarSagi, D., Lax, I., and Schlessinger, J. (1997). A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/M APK signaling pathway. Cell 89, 693-702.
24. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
25. Laskowski, R.A., Mac Arthur, M.W., Moss, D.S., and Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
26. Lemmon, M.A., and Schlessinger, J. (1994). Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sei. 19, 459-463.
27. Merrit, E.A., and Bacon, D.U. (1997). RasteiSD: photorealistic molecular graphics. Methods Enzymol. 277, 505-524.
28. Miki, T., Fleming, T.P., Bottaro, O.P., Rubin, J.S., Ron, D., and Aaronson, S.A. (1991). Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 251, 72-75.
29. Miki, T., Bottaro, O.P., Fleming, T.P., Smith, C.L., Burgess, W.H., Chan, A.M., and Aaronson, S.A. (1992). Determination of ligandbinding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sei. USA 89, 246-250.
30. Mohammadi, M., Dionne, C.A., Li, W., Li, N., Spivak, T., Honegger, A.M., Jaye, M., and Schlessinger, J. (1992). Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358, 681-684.
31. Naski, M.C., and Ornitz, D.M. (1998). FGF signaling in skeletal development. Front Biosci. 3, D781-D794.
32. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50, 157-163.
33. Niche-Ms, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
34. Noe, V., Willems, J., Vandekerckhove, J., Roy, F.V., Bruyneel, E., and Mareel, M. (1999). Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherin-specific peptides. J. Cell Sei. 772, 127-135.
35. Ornitz, D.M., Yayon, A., Flanagan, J.G., Svahn, C.M., Levi, E., and Leder, P. (1992). Heparin is required for cell-free binding of bFGF to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 72, 240-247.
36. Ornitz, D.M., Xu, J., Colvin, J.S., McEwen, D.G., MacArthur, C.A., Coulier, F., Gao, G., and Goldfarb, M. (1996). Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 277, 15292-15297.
37. Otwinowski, Z. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study Weekend, L Sawyer, N. Isaacs, and S. Burley, eds. (Daresbury, UK: SERC Daresbury Laboratory).
38. Pantoliano, M.W., Horlick, R.A., Springer, B.A., Van Dyk, D.E., Tobery, T., Wetmore, D.R., Lear, J.D., Nahapetian, A.T., Bradley, J.D., and Sisk, W.P. (1994). Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 33, 10229-10248.
39. Pawson, T. (1995). Protein modules and signaling networks. Nature 373, 573-580.
40. 2+ but not mitogenesis. Nature 358, 678-681.
41. Roghani, M., Mansukhani, A., Dell'Era, P., Bellosta, P., Basilico, C., Rifkin, D.B., and Moscatelli, D. (1994). Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269, 3976-3984.
42. Schlessinger, J., Lax, I., and Lemmon, M. (1995). Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83, 357-360.
43. Shapiro, L, Fannon, A.M., Kwong, P.D., Thompson, A., Lehmann, M.S., Grubel, G., Legrand, J.F., Als-Nielsen, J., Colman, D.R., and Hendrickson, W.A. (1995). Structural basis of cell-cell adhesion by cadherins. Nature 374, 327-337.
44. Spivak-Kroizman, T., Lemmon, M.A., Dikic, I., Ladbury, U.E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., and Lax, I. (1994). Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024.
45. Springer, B.A., Pantoliano, M.W., Barbera, F.A., Gunyuzlu, P.L., Thompson, L.D., Herblin, W.F., Rosenfeld, S.A., and Book, G.W. (1994). Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 269, 26879-26884.
46. Wang, F., Kan, M., Van, G., Xu, J., and McKeehan, W.L (1995). Alternately spliced NH2-terminal immunoglobulin-like loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. J. Biol. Chem. 270,10231 -10235.
47. Wang, F., Kan, M., McKeehan, K., Jang, J.H., Feng, S., and McKeehan, W.L. (1997). A homeo-interaction sequence in the ectodomain of the fibroblast growth factor receptor. J. Biol. Chem. 272, 23887-23895.
48. Wang, F., Lu, W., McKeehan, K., Mohamedali, K., Gabriel, J.L, Kan, M., and McKeehan, W.L. (1999). Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex. Biochemistry 38, 160-171.
49. Williams, A.F., and Barclay, A.N. (1988). The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol. 6, 381-405.
50. Yamaguchi, F., Saya, H., Bruner, U.M., and Morrison, R.S. (1994). Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl. Acad. Sei. USA 91, 484-488.
51. Yayon, A., Zimmer, Y., Shen, G.H., Avivi, A., Yarden, Y., and Givol, D. (1992). A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EM BO J. 11, 1885-1890.
52. Yayon, A., Aviezer, D., Safran, M., Gross, J.L, Heldman, Y., Cabilly, S., Givol, D., and Katchalski-Katzir, E. (1993). Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc. Natl. Acad. Sei. USA 90, 10643-10647.
53. Zhang, J.D., Cousens, L.S., Barr, P.J., and Sprang, S.R. (1991). Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc. Natl. Acad. Sei. USA 88, 3446-3450.
54. Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G.M., Arakawa, T., Hsu, B.T., and Rees, D.C. (1991). Three-dimensional structures of acidic and basic fibroblast growth factors. Science 257, 90-93.
55. Zhu, H., Ramnarayan, K., Anchin, J., M iao, W.Y., Sereno, A., M illman, L, Zheng, J., Balaji, V.N., and Wo Iff, M.E. (1995). Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis. J. Biol. Chem. 270, 21869-21874.
56. Zhu, H., Anchin, J., Ramnarayan, K., Zheng, J., Kawai, T., Mong, S., and Wolff, M .E. (1997). Analysis of high-affinity binding determinants in the receptor binding epitope of basic fibroblast growth factor. Protein Eng. 10, 417-421.
57. Zhu, H., Ramnarayan, K., Menzel, P., Miao, Y., Zheng, J., and Mong, S. (1998). Identification of two new hydrophobic residues on basic fibroblast growth factor important for fibroblast growth factor receptor binding. Protein Eng. 11, 937-940.